Semaglutide (GLP-1 medicine) – Patient Information (Australia)

Semaglutide is a medicine used to improve blood sugar control and, for some people, to support weight loss. It belongs to a group of medicines called GLP-1 receptor agonists. In Australia, semaglutide products are used under specific brand names and dosing regimens, depending on the condition being treated.

This page explains what semaglutide is, how it works, what to expect, key safety information, and practical tips for using it. It also covers important interactions (including food and alcohol) and outlines where to find guidance and availability in Australia.

Key product information (at a glance)

What is semaglutide used for?

Semaglutide is used in adults for conditions where improving metabolic health is important. Depending on the specific product and your situation, it may be used for:

• Type 2 diabetes: To improve blood sugar control, often alongside diet and exercise.
• Weight management: To support weight loss in people who meet relevant clinical criteria.
• Cardiovascular risk considerations: In some people with type 2 diabetes at higher cardiovascular risk, semaglutide may be considered as part of overall risk management (this depends on individual clinical factors and product guidance).

In Australia, availability and eligibility depend on the product, local prescribing guidelines, and regulatory status. Your healthcare team can help determine whether semaglutide is appropriate for you.

How semaglutide works (mechanism of action)

Semaglutide mimics the natural hormone GLP-1 (glucagon-like peptide-1). This hormone plays a role in regulating blood sugar and appetite. Semaglutide works through several mechanisms:

• Stimulates insulin release when glucose is high: This helps lower blood glucose after meals, reducing the risk of low blood sugar compared with some other diabetes medicines.
• Reduces glucagon secretion: Glucagon increases blood sugar. Semaglutide helps temper this response.
• Slows gastric emptying: Food stays in the stomach longer, which can reduce appetite and lead to a more gradual rise in blood sugar.
• Improves satiety (feeling full): Many people experience reduced hunger and smaller portion sizes.

Because semaglutide affects appetite and digestion, early side effects such as nausea may occur—especially when starting treatment or increasing dose.

Pharmacokinetics (how the body handles semaglutide)

While individual experience varies, understanding the general pharmacokinetic profile can help with expectations:

• Absorption: After a subcutaneous injection, semaglutide is absorbed gradually.
• Time to maximum concentration: The peak level in the bloodstream typically occurs within a few days, supporting once-weekly dosing for many semaglutide products.
• Half-life: Semaglutide has a long duration of action, which is one reason it is given weekly.
• Metabolism and clearance: Semaglutide is processed via pathways typical of peptide breakdown, rather than primarily relying on kidney filtration.

Dosing schedules and starting doses vary by product and indication. Your healthcare team will provide the correct plan for your specific semaglutide brand and strength.

Typical dosing and timing

Semaglutide is commonly administered as a once-weekly injection. Dose escalation is used to improve tolerability and reduce gastrointestinal side effects.

General timing principles

• Choose a day: Pick a day of the week that fits your routine. Try to inject on the same day each week.
• If you need to change the day: Your plan may allow shifting the injection day, often with guidance about the interval between doses. Always follow product-specific instructions.
• Follow dose escalation: Starting at a lower dose and gradually increasing is typical.

Example dose escalation approach (illustrative)

Specific schedules depend on the product and indication. Below is an illustrative example of how escalation may be structured. Always use the dosing regimen provided for your specific semaglutide product:

If you miss a dose, the best approach depends on how close you are to the next scheduled injection. Refer to the product instructions or your healthcare team for the safest plan.

Food interactions and meal considerations

Semaglutide slows gastric emptying and can influence how quickly you feel full after eating. In most cases, there are no strict “prohibited” foods, but practical meal strategies can help:

• Eat smaller meals: Many people find smaller portions reduce nausea and reflux.
• Prioritise protein and fibre: This can help maintain nutrition while feeling satisfied.
• Avoid very large, high-fat meals: These may worsen stomach discomfort.
• Stay hydrated: Especially if you experience vomiting or diarrhoea.
• Blood sugar monitoring: If you use other diabetes medicines, eating patterns can affect glucose. Semaglutide may improve glucose, so monitoring and adjustment may be required under clinical guidance.

Important: Because semaglutide affects appetite, you may eat less than usual. If you develop significant nausea, persistent vomiting, or inability to keep fluids down, seek medical advice.

Alcohol and medicine interactions

Alcohol can affect blood sugar and may worsen gastrointestinal side effects (such as nausea, reflux, and dehydration). The best approach depends on your overall health and your other medications.

• General caution: If you drink alcohol, do so in moderation and consider avoiding it during the initial weeks or after dose increases if you notice nausea.
• Dehydration risk: Alcohol can contribute to dehydration, which may be more concerning if you experience vomiting or diarrhoea.
• Low blood sugar: While semaglutide alone has a lower risk of hypoglycaemia, alcohol combined with other diabetes medicines (especially those that can cause low blood sugar) may increase risk.
• Liver concerns: If you have liver disease, ask a healthcare professional for tailored advice.

For the safest plan, tell your healthcare team about your alcohol intake and all medicines you use.

Medicines interactions (other than alcohol)

Semaglutide can influence digestion and appetite, which may indirectly affect how other medicines behave. Some interactions are especially important:

• Insulin and sulfonylureas: When semaglutide is used with medicines that lower blood sugar, the combined effect can increase the chance of hypoglycaemia. Dose adjustments may be needed.
• Oral medicines with tight timing requirements: Because gastric emptying slows, some tablets may absorb differently. This is not usually an issue for most medicines, but it can matter for medicines with narrow therapeutic windows.
• Oral contraceptives: Changes in stomach emptying and gastrointestinal side effects (vomiting/diarrhoea) may affect absorption. If you experience significant vomiting soon after taking a pill, follow your contraceptive guidance.
• Other GLP-1 medicines: Do not combine semaglutide with another GLP-1 receptor agonist unless specifically advised.
• Warfarin and anticoagulants: If you take warfarin, monitor closely as guidance may require adjustment and more frequent blood testing after starting or changing dose.

Always provide a full list of your medicines (including vitamins, supplements, and herbal products) to your pharmacist or clinician.

Safety profile and precautions

Like all medicines, semaglutide can cause side effects. Most are gastrointestinal and are often more noticeable early in treatment or after dose increases. Understanding warning signs helps you seek help early if needed.

Common side effects

• Nausea
• Vomiting
• Diarrhoea
• Constipation
• Stomach pain or discomfort
• Reduced appetite
• Burping, indigestion, or reflux

Less common but important warnings

• Dehydration: If vomiting/diarrhoea is severe, dehydration can occur. This may affect kidney function.
• Gallbladder problems: Weight loss can increase gallstone risk. Watch for right upper abdominal pain, fever, or persistent nausea.
• Pancreatitis (rare): Seek urgent medical advice if you develop severe, persistent abdominal pain, especially if it radiates to the back, with or without vomiting.
• Hypoglycaemia risk: More likely when combined with insulin or medicines that can cause low blood sugar.
• Allergic reactions: Rarely, people can experience rash, swelling, or breathing difficulties. Seek emergency care if serious symptoms occur.

Who should take extra care?

Discuss semaglutide with a clinician if you have:

• History of pancreatitis
• Serious gastrointestinal disease (e.g., severe gastroparesis)
• Gallbladder disease or gallstones
• Kidney problems (especially if at risk of dehydration)
• Diabetic retinopathy (especially if vision changes occur after glucose improvements)
• Use of medicines that can cause hypoglycaemia

If you are pregnant, breastfeeding, or planning pregnancy, discuss risks and benefits with a healthcare professional.

Practical use tips (how to get the best results)

Many people do well with semaglutide when they follow simple, practical steps—especially during the first weeks.

Injection technique and routine

• Rotate injection sites: Common sites include the abdomen, thigh, or upper arm. Rotate to reduce irritation.
• Use consistent timing: A weekly schedule helps the body maintain steady levels.
• Prepare your routine: Keep the device and supplies in an easy-to-reach place to reduce missed doses.

Managing nausea and appetite changes

• Start low, go slow: Stick to the planned dose escalation schedule.
• Eat slowly: Give your body time to signal fullness.
• Choose bland, smaller meals: If you feel nauseated, smaller meals can be easier to tolerate.
• Consider spacing fluids: Sip water regularly rather than large volumes at once.
• Track symptoms: Note what triggers symptoms (large meals, fatty meals, alcohol) to adjust habits.

When to seek urgent help

Get urgent medical advice if you experience:

• Severe, persistent abdominal pain (especially radiating to the back)
• Signs of dehydration (dizziness, reduced urination, inability to keep fluids down)
• Symptoms of allergic reaction (swelling of face/lips, difficulty breathing)
• Severe or prolonged vomiting/diarrhoea
• Symptoms of hypoglycaemia (confusion, shakiness, sweating)—particularly if you are on insulin or sulfonylureas

Alternative options

Depending on your condition, your healthcare team may consider other strategies. Alternatives can include:

• Other GLP-1 receptor agonists: Different formulations and dosing schedules may be available.
• Dual-action medicines (GIP/GLP-1): Some patients may respond to other incretin-based approaches.
• Weight management approaches: Lifestyle programs, structured nutrition and exercise plans, and other medication classes where appropriate.
• Diabetes medicines: Metformin, SGLT2 inhibitors, DPP-4 inhibitors, and others may be considered based on individual needs and risk factors.

If semaglutide is not suitable or not well-tolerated, discussing alternative treatment options with your clinician is recommended.

Australia: market, legal and guidance context

In Australia, semaglutide products are regulated through the national medicines framework. Availability may vary by brand and strength, and eligibility can differ by indication. Guidance may also be updated as new evidence emerges and as regulators and professional bodies refine recommendations.

For the most current, authoritative information in Australia, consider checking:

• Australian Government TGA (Therapeutic Goods Administration) for regulatory status, product details, and safety updates.
• Professional clinical guidance from Australian health organisations (often updated to reflect new evidence).
• Diabetes Australia and related resources for educational and self-management advice.

Availability can be influenced by manufacturing timelines, prescribing criteria, supply constraints, and changing demand. Your pharmacist can provide advice about expected delivery times and product options.

Recent guidance (what typically gets updated)

While the exact details can vary, guidance updates for semaglutide commonly focus on:

• Dose escalation and tolerability: strategies to minimise gastrointestinal side effects
• Safety monitoring: kidney function considerations, dehydration risk, and gallbladder warning signs
• Cardiovascular outcomes and risk stratification: who may benefit most in higher-risk groups
• Use in special populations: e.g., people with kidney impairment, retinopathy considerations, and pregnancy/breastfeeding advice
• Interactions: specific recommendations for insulin, sulfonylureas, warfarin, and other medicines

If you’d like, your healthcare professional or pharmacist can review the latest recommendations applicable to your situation.

Delivery and availability in Australia

Semaglutide products may be delivered directly to eligible customers by registered supply partners, with delivery times depending on location within Australia and stock availability. To support safe delivery and storage:

• Check storage requirements: Many injectable products require refrigeration before use. Some may allow limited room-temperature handling after preparation—follow the specific product label.
• Plan for receipt: Arrange delivery so the parcel is collected promptly.
• Keep temperature in mind: During hot Australian weather, consider insulated delivery options if offered by the supplier.
• Track your order: Tracking helps you know when to collect the parcel.

Availability can change. If a specific strength or brand is temporarily out of stock, alternatives with the same active ingredient may sometimes be considered—subject to clinical appropriateness and local regulations.

How to store semaglutide (general advice)

Storage instructions differ slightly between products, but the general principles are:

• Store according to the label (commonly refrigerated before first use).
• Do not freeze.
• Keep away from light and heat.
• Keep out of reach of children.

Always read the specific product consumer medicine information for exact instructions for your device and brand.

FAQ – Semaglutide (Australia)

1) What is semaglutide?

Semaglutide is a GLP-1 receptor agonist medication given by subcutaneous injection. It helps improve blood sugar and can reduce appetite, supporting weight loss for people who meet relevant criteria.

2) How often do I take semaglutide?

Many semaglutide products are administered once weekly. The exact frequency and dose depend on the product and indication. Follow your product instructions and clinician guidance.

3) When should I take it during the day?

Timing of day is usually flexible, as long as you inject consistently on the correct weekly day. If gastrointestinal side effects occur, some people find certain times of day more comfortable—choose what suits you.

4) What should I do if I miss a dose?

The appropriate response depends on how long it’s been since your missed dose and how close you are to the next one. Refer to your product-specific instructions or ask your pharmacist for personalised advice.

5) Can I eat normally while taking semaglutide?

Many people continue to eat normally but often with smaller portions. Because it slows digestion and increases fullness, large or high-fat meals may worsen nausea. A balanced diet with smaller meals can help.

6) Is there a specific diet I must follow?

There is no single universal diet required. However, lifestyle changes—such as reducing excess calories, increasing physical activity, and choosing nutrient-dense foods—improve results and support long-term health.

7) Does semaglutide interact with alcohol?

Alcohol may worsen nausea, increase dehydration risk, and affect blood sugar—especially if you take other diabetes medicines. If you choose to drink, do so in moderation and consider avoiding it during the initial period or after dose increases if side effects occur.

8) Will semaglutide cause low blood sugar?

Semaglutide alone has a lower risk of hypoglycaemia than some other diabetes treatments. However, if you use insulin or medicines such as sulfonylureas, the risk may be higher. Monitoring and possible dose adjustment may be needed.

9) What side effects are most common?

The most common side effects are gastrointestinal, including nausea, vomiting, diarrhoea, constipation, and stomach discomfort. These often improve over time and with dose escalation.

10) When should I stop semaglutide or seek help?

Seek urgent medical advice for severe abdominal pain, signs of dehydration, allergic reactions, or persistent vomiting/diarrhoea. Do not stop treatment suddenly without medical advice—discuss concerns promptly with your healthcare team.

11) What are the storage requirements?

Storage requirements depend on the exact product label. Many injectable forms require refrigeration before use and should never be frozen. Always check the consumer medicine information for your specific brand and device.

12) Are there alternative treatments if semaglutide isn’t suitable?

Yes. Alternatives may include other incretin-based medicines, different diabetes medications, or other weight-management approaches, depending on your individual goals and clinical factors.

Important patient note

Medicines information can’t cover every individual situation. If you are unsure whether semaglutide is appropriate for you, or if you have questions about side effects, interactions, or your weekly injection routine, speak with a qualified healthcare professional.

Always read the product consumer medicine information supplied with your specific semaglutide brand for complete instructions and safety details.